Abstract
Mitochondrial disease can arise due to pathogenic sequence variants in the mitochondrial DNA (mtDNA) that prevent cells from meeting their energy demands. Mitochondrial diseases are often fatal and currently there are no treatments directed towards the underlying cause of disease. Pathogenic variants in mtDNA often exist in a state of heteroplasmy, with coexistence of pathogenic and wild type mtDNA. The load of heteroplasmy, defined as the relative amount of pathogenic mtDNA to wild type mtDNA, corresponds to timing and symptom severity. Thus, changing the heteroplasmy load may lead to a shift in disease onset and symptom severity. Here we review techniques aimed at preventing inheritance of pathogenic mtDNA via mitochondrial replacement therapy (MRT) and strategies geared toward shifting of heteroplasmy in individuals with active mitochondrial disease. MRT strategies seek to create embryos with the nuclear genetic makeup of the intended parents and wild type mtDNA from a donor in order to avoid known maternal pathogenic variants. Heteroplasmy shift approaches in patients are of two categories: nuclease dependent and nuclease independent strategies. Despite initial success in mouse models and patient cells, these techniques have not reached clinical use. Translational attempts in this area are urgently needed to improve therapies for a currently untreatable set of disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bacman SR, Williams SL, Hernandez D, Moraes CT (2007) Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a “differential multiple cleavage-site” model. Gene Ther 14(18):1309–1318. https://doi.org/10.1038/sj.gt.3302981
Bacman SR, Williams SL, Pinto M, Peralta S, Moraes CT (2013) Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat Med 19(9):1111–1113. https://doi.org/10.1038/nm.3261
Bayona-bafaluy MP, Blits B, Battersby BJ, Shoubridge EA, Moraes CT (2005) Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. PNAS 102(40):14392–14397
Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S (2006) Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res 34(19):5402–5415. https://doi.org/10.1093/nar/gkl655
Chinnery PF, Hudson G (2013) Mitochondrial genetics. Br Med Bull 106(1):135–159. https://doi.org/10.1093/bmb/ldt017
Craven L, Tuppen HA, Greggains GD, Harbottle SJ, Murphy JL, Cree LM et al (2010) Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 465(7294):82–85. https://doi.org/10.1038/nature08958
Crawford N, Prendergast D, Oehlert JW, Shaw GM, Stevenson DK, Rappaport N et al (2017) Divergent patterns of mitochondrial and nuclear ancestry are associated with the risk for preterm birth. J Pediatr 194:40–46.e4. https://doi.org/10.1016/j.jpeds.2017.10.052
de Laat P, Fleuren LHJ, Bekker MN, Smeitink JAM, Janssen MCH (2015) Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome. Mitochondrion 25:98–103. https://doi.org/10.1016/j.mito.2015.10.005
Dejean LM, Martinez-Caballero S, Kinnally KW (2006) Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis? Cell Death Differ 13(8):1387–1395. https://doi.org/10.1038/sj.cdd.4401949
Emani SM, McCully JD (2018) Mitochondrial transplantation: applications for pediatric patients with congenital heart disease. Transl Pediatr 7(2):169–175. https://doi.org/10.21037/tp.2018.02.02
Emani SM, Piekarski BL, Harrild D, del Nido PJ, McCully JD (2017) Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury. J Thorac Cardiovasc Surg 154(1):286–289. https://doi.org/10.1016/j.jtcvs.2017.02.018
Falabella M, Kolesar JE, Xiang IM, Wang T, Horne W, Wallace C et al (2018) G-quadruplex dynamics contribute to epigenetic regulation of mitochondrial function. BioRXiv. https://doi.org/10.1101/359703
Fan W, Waymire KG, Narula N, Li P, Rocher C, Coskun PE et al (2008) A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science 319(5865):958–962. https://doi.org/10.1126/science.1147786
Gammage PA, Moraes CT, Minczuk M (2017) Mitochondrial genome engineering: the revolution may not be CRISPR-Ized. Trends Genet 34(2):101–110. https://doi.org/10.1016/j.tig.2017.11.001
Gershoni M, Levin L, Ovadia O, Toiw Y, Shani N, Dadon S et al (2014) Disrupting mitochondrial-nuclear coevolution affects OXPHOS complex i integrity and impacts human health. Genome Biol Evol 6(10):2665–2680. https://doi.org/10.1093/gbe/evu208
Greenfield A, Braude P, Flinter F, Lovell-Badge R, Ogilvie C, Perry ACF (2017) Assisted reproductive technologies to prevent human mitochondrial disease transmission. Nat Biotechnol 35(11):1059–1068. https://doi.org/10.1038/nbt.3997
Hamilton ML, Guo Z, Fuller CD, Van Remmen H, Ward WF, Austad SN et al (2001) A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res 29(10):2117–2126. https://doi.org/10.1093/nar/29.10.2117
Hänsel-Hertsch R, Beraldi D, Lensing SV, Marsico G, Zyner K, Parry A et al (2016) G-quadruplex structures mark human regulatory chromatin. Nat Genet 48(10):1267–1272. https://doi.org/10.1038/ng.3662
Herbert M, Turnbull D (2018) Progress in mitochondrial replacement therapies. Nat Rev Mol Cell Biol 19(2):71–72. https://doi.org/10.1038/nrm.2018.3
Jo A, Ham S, Lee GH, Lee Y, Kim S, Lee Y et al (2015) Efficient mitochondrial genome editing by CRISPR/Cas9. Biomed Res Int 201.(Article ID 305716:1–10. https://doi.org/10.1155/2015/305716
Kang E, Wu J, Gutierrez NM, Koski A, Tippner-Hedges R, Agaronyan K et al (2016) Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations. Nature 540(7632):270–275. https://doi.org/10.1038/nature20592
Kaufman BA, Van Houten B (2017) POLB: a new role of DNA polymerase beta in mitochondrial base excision repair. DNA Repair 60.(November:A1–A5. https://doi.org/10.1016/j.dnarep.2017.11.002
Kazak L, Reyes A, Holt IJ (2012) Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol 13(10):659–671. https://doi.org/10.1038/nrm3439
Kim Y-G, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. PNAS 93.(February:1156–1160
Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF et al (2009) Gene-environment interactions in Leber hereditary optic neuropathy. Brain 132(9):2317–2326. https://doi.org/10.1093/brain/awp158
Latorre-Pellicer A, Moreno-Loshuertos R, Lechuga-Vieco AV, Sánchez-Cabo F, Torroja C, Acín-Pérez R et al (2016) Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing. Nature 535(7613):561–565. https://doi.org/10.1038/nature18618
Lesnefsky EJ, Chen Q, Slabe TJ, Stoll MSK, Minkler PE, Hassan MO et al (2004) Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am J Physiol Heart Circ Physiol 287(1):H258–H267. https://doi.org/10.1152/ajpheart.00348.2003
Lin Y-F, Schulz AM, Pellegrino MW, Lu Y, Shaham S, Haynes CM (2016) Maintenance and propagation of a deleterious mitochondrial genome by the mitochondrial unfolded protein response. Nature 533(7603):1–8. https://doi.org/10.1038/nature17989
Ma H, O’Neil RC, Marti Gutierrez N, Hariharan M, Zhang ZZ, He Y et al (2017) Functional human oocytes generated by transfer of polar body genomes. Cell Stem Cell 20(1):112–119. https://doi.org/10.1016/j.stem.2016.10.001
Malarky MA (2017, August 4). Retrieved October 4, 2018, from https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ComplianceActivities/Enforcement/UntitledLetters/UCM570225.pdf
Masuzawa A, Black KM, Pacak CA, Ericsson M, Barnett RJ, Drumm C et al (2013) Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury. AJP: Heart Circ Physiol 304(7):H966–H982. https://doi.org/10.1152/ajpheart.00883.2012
Matthew Liao S (2017) Do mitochondrial replacement techniques affect qualitative or numerical identity? Bioethics 31(1):20–26. https://doi.org/10.1111/bioe.12308
McCully JD, Cowan DB, Pacak CA, Toumpoulis IK, Dayalan H, Levitsky S (2009) Injection of isolated mitochondria during early reperfusion for cardioprotection. Am J Phys Heart Circ Phys 296(1):H94–H105. https://doi.org/10.1152/ajpheart.00567.2008
Melber A, Haynes CM (2018) UPR mt regulation and output: a stress response mediated by mitochondrial-nuclear communication. Cell Res 28(3):281–295. https://doi.org/10.1038/cr.2018.16
Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148(6):1145–1159. https://doi.org/10.1016/j.cell.2012.02.035
Rahman S, Poulton J, Marchington D, Suomalainen A (2001) Decrease of 3243 A→G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet 68(1):238–240. https://doi.org/10.1086/316930
Reardon S (2017) Genetic details of controversial “three-parent baby” revealed. Nature 544:17–18. https://doi.org/10.1038/nature.2017.21761
Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA (2007) Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 35(2):235–242. https://doi.org/10.1002/mus.20688
Ross JM, Stewart JB, Hagström E, Brené S, Mourier A, Coppotelli G et al (2013) Germline mitochondrial DNA mutations aggravate ageing and can impair brain development. Nature 501(7467):412–415. https://doi.org/10.1038/nature12474
Røyrvik EC, Burgstaller JP, Johnston IG (2016) mtDNA diversity in human populations highlights the merit of haplotype matching in gene therapies. Mol Hum Reprod 22(11):809–817. https://doi.org/10.1093/molehr/gaw062
Saneto RP, Sedensky MM (2013) Mitochondrial disease in childhood: MtDNA encoded. Neurotherapeutics 10(2):199–211. https://doi.org/10.1007/s13311-012-0167-0
Santorelli FM, Shanske S, Macaya A, DeVivo DC, DiMauro S (1993) The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh’s syndrome. Ann Neurol 34(6):827–834. https://doi.org/10.1002/ana.410340612
Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW et al (2008) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63(1):35–39. https://doi.org/10.1002/ana.21217
Smith PM, Lightowlers RN (2011) Altering the balance between healthy and mutated mitochondrial DNA. J Inherit Metab Dis 34(2):309–313. https://doi.org/10.1007/s10545-010-9122-6
Sondheimer N, Glatz CE, Tirone JE, Deardorff MA, Krieger AM, Hakonarson H (2011) Neutral mitochondrial heteroplasmy and the influence of aging. Hum Mol Genet 20(8):1653–1659. https://doi.org/10.1093/hmg/ddr043
Stein A, Sia EA (2017) Mitochondrial DNA repair and damage tolerance. Front Biosci (Landmark Edition) 22:920–943. Retrieved fromhttp://www.ncbi.nlm.nih.gov/pubmed/27814655
Sue CM, Quigley A, Katsabanis S, Kapsa R, Crimmins DS, Byrne E, Morris JGL (1998) Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J Neurol Sci 161(1):36–39. https://doi.org/10.1016/S0022-510X(98)00179-8
Suissa S, Wang Z, Poole J, Wittkopp S, Feder J, Shutt TE et al (2009) Ancient mtDNA genetic variants modulate mtDNA transcription and replication. PLoS Genetics 5(5). https://doi.org/10.1371/journal.pgen.1000474
Tachibana M, Amato P, Sparman M, Woodward J, Sanchis DM, Ma H et al (2013) Towards germline gene therapy of inherited mitochondrial diseases. Nature 493(7434):627–631. https://doi.org/10.1038/nature11647
Taivassalo T, Fu K, Johns T, Arnold D, Karpati G, Shoubridge EA (1999) Gene shifting: a novel therapy for mitochondrial myopathy. Hum Mol Genet 8(6):1047–1052
Taivassalo T, Gardner JL, Taylor RW, Schaefer AM, Newman J, Barron MJ et al (2006) Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 129(12):3391–3401. https://doi.org/10.1093/brain/awl282
Taylor RW, Turnbull DM (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6(5):389–402. https://doi.org/10.1038/nrg1606
Viscomi C, Bottani E, Zeviani M (2015) Emerging concepts in the therapy of mitochondrial disease. Biochim Biophys Acta Bioenerg 1847(6–7):544–557. https://doi.org/10.1016/j.bbabio.2015.03.001
Watts G, Braude P, Flinter F, Harding S, Lewens T, Parker M (2012) Novel techniques for the prevention of mitochondrial DNA disorders: an ethical review. Nuffield Council on Bioethics, London
Wang T, Sha H, Ji D, Zhang HL, Chen D, Cao Y, Zhu J (2014) Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell 157(7):1591–1604. https://doi.org/10.1016/j.cell.2014.04.042
Wonnapinij P, Chinnery PF, Samuels DC (2008) The distribution of mitochondrial DNA heteroplasmy due to random genetic drift. Am J Hum Genet 83(5):582–593. https://doi.org/10.1016/j.ajhg.2008.10.007
Yamada M, Emmanuele V, Sanchez-Quintero MJ, Sun B, Lallos G, Paull D et al (2016) Genetic drift can compromise mitochondrial replacement by nuclear transfer in human oocytes. Cell Stem Cell 18(6):749–754. https://doi.org/10.1016/j.stem.2016.04.001
Youle RJ, Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12(1):9–14. https://doi.org/10.1038/nrm3028
Zhang J, Liu H, Luo S, Lu Z, Chávez-Badiola A, Liu Z et al (2017) Live birth derived from oocyte spindle transfer to prevent mitochondrial disease. Reprod Biomed Online 35(6):750. https://doi.org/10.1016/j.rbmo.2017.07.008
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Naeem, M.M., Sondheimer, N. (2019). Heteroplasmy Shifting as Therapy for Mitochondrial Disorders. In: Urbani, A., Babu, M. (eds) Mitochondria in Health and in Sickness. Advances in Experimental Medicine and Biology, vol 1158. Springer, Singapore. https://doi.org/10.1007/978-981-13-8367-0_14
Download citation
DOI: https://doi.org/10.1007/978-981-13-8367-0_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8366-3
Online ISBN: 978-981-13-8367-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)